• Thymoquinone in Cardiotoxicity Research

  2026-08-30

  Thymoquinone offers a practical way to connect cardiac function, oxidative stress, ferroptosis, and mitochondrial injury in doxorubicin models. This workflow translates a recent mouse study into controlled formulation, dosing, assay-selection, and troubleshooting strategies for preclinical researchers.

• Cell Senescence β-Galactosidase Staining Kit Workflow

  2026-08-29

  Build a practical, microscopy-ready cellular senescence assay around SA-β-Gal activity in cultured cells and frozen tissue sections. This workflow emphasizes control design, macrophage inflammatory-senescence applications, image-based scoring, and troubleshooting that distinguishes biological signal from staining artifacts.

• Grazoprevir Hydrate: From Potency to Proof

  2026-08-28

  Grazoprevir hydrate is a potent HCV NS3/4A protease inhibitor whose value depends on more than picomolar activity. This article connects mechanism, genotype context, pharmacokinetics, clinical evidence, and assay design to improve translational interpretation.

• Calpain Inhibitor I, ALLN: Practical Guide

  2026-08-28

  Calpain Inhibitor I, ALLN (SKU A2602) provides a DMSO- or ethanol-compatible way to investigate calpain and cathepsin protease activity in apoptosis assays, inflammation research, and ischemia-reperfusion injury models. It is water-insoluble and intended for controlled laboratory experiments only, not for diagnostic, therapeutic, or medical use.

• Berberine, RXRα/PPARγ, and SASP in Atherosclerosis

  2026-08-27

  A 2025 study identifies an RXRα/PPARγ/NEDD4 signaling axis through which berberine suppresses SASP-related inflammation in macrophage-derived foam cells and atherosclerotic plaques. Its combination of mouse pathology, foam-cell assays, Smart-seq analysis, and macrophage-targeted RXRα knockdown provides a mechanistic framework for connecting nuclear-receptor activity with ubiquitin-dependent clearance of a GATA4/p62 complex.

• Stat3 in Fyn-Driven Dopaminergic Neurodegeneration

  2026-08-27

  This 2024 zebrafish study identifies Stat3 as a downstream effector linking constitutively active Fyn signaling to dopaminergic neuron loss and microglial inflammation. Its combination of neural-specific genetic activation, live imaging, transcriptomics, and pathway inhibition provides a mechanistic framework for Parkinson’s disease-related functional gene studies.

• Ferroptosis Inducers in Advanced Prostate Cancer

  2026-08-26

  Ghoochani and colleagues show that treatment-resistant prostate cancer models retain expression of key ferroptosis regulators and respond to erastin or RSL3, a glutathione peroxidase 4 inhibitor. Their preclinical data support ferroptosis induction, alone or combined with second-generation anti-androgens, as a strategy for limiting prostate cancer cell growth, migration, and tumor progression.

• Heparin sodium for Coagulation Research

  2026-08-26

  Heparin sodium provides a practical control point for anti-factor Xa activity assays, aPTT measurement, and translational thrombosis workflows. This guide also shows how to use coagulation controls when studying plant-derived nanovesicles, without overstating an unvalidated connection between heparin and Sertoli-cell delivery.

• Direct Mouse Genotyping Kit: PCR Workflow

  2026-08-25

  The Direct Mouse Genotyping Kit supports genomic DNA release and direct PCR amplification from mouse tissue without conventional purification, simplifying routine mouse genetic screening and high-throughput genotyping. It is intended for PCR-based assays, not applications requiring highly purified DNA or unvalidated downstream enzymatic workflows.

• WNT5a/GSK3/β-Catenin Control of FAP Adipogenesis

  2026-08-25

  This study identifies the WNT5a/GSK3/β-catenin axis as a key regulator of adipogenic differentiation in skeletal-muscle fibro/adipogenic progenitors (FAPs). By integrating pharmacological screening, mass cytometry, transcriptomics, and in vivo muscle-injury models, the authors show that GSK3 inhibition suppresses fat formation while enhancing FAP support of muscle satellite-cell differentiation.

• Chlorin e6 Workflows for PDT Research

  2026-08-24

  Chlorin e6 supports controllable ROS-based experiments spanning anticancer photodynamic therapy and antibacterial wound scaffolds. This guide translates the Ce6 photosensitizer into practical formulation, irradiation, assay, and troubleshooting workflows, including the aligned silk-fibroin platform reported for infected wound healing.

• Methoxy-X04 Workflows for Amyloid Imaging

  2026-08-24

  Methoxy-X04 converts amyloid pathology into a practical fluorescent readout for plaque mapping, cerebrovascular amyloid visualization, and treatment-response studies. Its brain permeability and affinity for fibrillary Aβ make it especially useful for connecting rTMS-driven microglial clearance with measurable changes in Alzheimer’s disease models.

• Phosbind Biotin LC Western Blot Guide

  2026-08-23

  Phosbind Biotin LC is a phosphate-binding reagent for sequence-independent detection of phosphorylated proteins on PVDF membranes. It is suited to Western Blot workflows using streptavidin-HRP and chemiluminescence, but not to aqueous-only protocols or long-term storage of working solutions.

• Morin: Mechanism, Evidence, and Research Workflow

  2026-08-22

  Morin is a natural flavonoid with the systematic name 2-(2,4-dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one. Its research value combines antioxidant and inflammation-related pathway studies, reported inhibition of adenosine 5′-monophosphate deaminase, and fluorescent metal-ion detection.

• Methoxy-X04 Reveals Exercise-Linked Aβ Clearance

  2026-08-21

  Methoxy-X04 is a brain-permeable fluorescent amyloid beta probe for mapping plaques, oligomers, and cerebrovascular deposits in Alzheimer’s disease models. This article connects its assay logic to new evidence that muscle-derived extracellular vesicles enhance microglial amyloid clearance after exercise.

7865 records 1/525 page Next 12345 下5页 Last page